, Volume 35, Issue 4, pp 1322–1329 | Cite as

Chronic Inflammation Is Correlated with Percentage of Body Fat Independent of the Burden of Infection

  • Katayoun Vahdat
  • Fatemeh Azizi
  • Keivan Zandi
  • Majid Assadi
  • Iraj Nabipour


The aim of this population-based study was to investigate the association of the percentage of body fat (BF) and high-sensitivity C-reactive protein (hs-CRP) when the infectious burden was adjusted for. A total of 1,546 subjects were randomly selected. BF was determined using bioelectrical impedance analysis. Sera were analyzed for IgG antibodies to Chlamydia pneumoniae, herpes simplex virus type 1, Helicobacter pylori, and cytomegalovirus using ELISA. Measurement of C-reactive protein (CRP) by a high-sensitivity CRP assay was performed. A linear relationship between an increase in the number of pathogens and CRP concentrations was observed (p = 0.007). Age-adjusted serum hs-CRP levels were correlated with percentage of BF in men (r = 0.28, p < 0.0001) and women (r = 0.37, p < 0.0001). In multiple regression analyses, hs-CRP showed significant correlations with percentage of BF after controlling for age, sex, cardiovascular risk factors, and the infectious burden was divided into two, three, and four pathogens [(β = 0.24, p < 0.0001), (β = 0.2 1, p < 0.0001), and (β = 0.23, p = <0.0001), respectively]. In conclusion, there was a strong association between hs-CRP and percentage of body fat independent of viral and bacterial pathogens that had been previously associated with coronary artery disease as well as carotid atherosclerosis.


obesity body fat C-reactive protein burden of infection adipose tissue 



This study was supported in part by a grant from Bushehr Province Technology and Research Committee, and Research Deputy of Bushehr University of Medical Science.


  1. 1.
    Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. The Journal of Allergy and Clinical Immunology 115: 911–919.PubMedCrossRefGoogle Scholar
  2. 2.
    Després, J.P. 2006. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. European Heart Journal Supplements 8: B4–B12.CrossRefGoogle Scholar
  3. 3.
    Kim, K., R.J. Valentine, Y. Shin, and K. Gong. 2008. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism 57: 1181–1189.PubMedCrossRefGoogle Scholar
  4. 4.
    Jialal, I., S. Devaraj, and S.K. Venugopal. 2004. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44: 6–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Centers for Disease Control and Prevention, American Heart Association, et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499–511.PubMedCrossRefGoogle Scholar
  6. 6.
    Ford, E.S. 1999. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22: 1971–1977.PubMedCrossRefGoogle Scholar
  7. 7.
    Hak, A.E., C.D. Stehouwer, M.L. Bots, K.H. Polderman, C.G. Schalkwijk, I.C. Westendorp, et al. 1999. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 1986–1991.PubMedCrossRefGoogle Scholar
  8. 8.
    Heilbronn, L.K., and P.M. Clifton. 2002. C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. The Journal of Nutritional Biochemistry 13: 316–321.PubMedCrossRefGoogle Scholar
  9. 9.
    Ziccardi, P., F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, et al. 2002. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804–809.PubMedCrossRefGoogle Scholar
  10. 10.
    Forouhi, N.G., N. Sattar, and P.M. McKeigue. 2001. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International Journal of Obesity and Related Metabolic Disorders 25: 1327–1331.PubMedCrossRefGoogle Scholar
  11. 11.
    Lemieux, I., A. Pascot, D. Prud’homme, N. Alméras, P. Bogaty, A. Nadeau, et al. 2001. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology 21: 961–967.PubMedCrossRefGoogle Scholar
  12. 12.
    Pou, K.M., J.M. Massaro, U. Hoffmann, R.S. Vasan, P. Maurovich-Horvat, M.G. Larson, et al. 2007. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116: 1234–1241.PubMedCrossRefGoogle Scholar
  13. 13.
    Faber, D.R., Y. van der Graaf, J. Westerink, and F.L.J. Visseren. 2010. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Atherosclerosis 212: 274–280.PubMedCrossRefGoogle Scholar
  14. 14.
    Despres, J.P. 2011. CRP: star trekking the galaxy of risk markers. Lancet 377: 441–442.PubMedCrossRefGoogle Scholar
  15. 15.
    Ebrahimi, A., I. Nabipour, K. Vahdat, S.M. Jafari, M. Fouladvand, M. Assadi, et al. 2009. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden. Diabetes Research and Clinical Practice 84: 296–302.PubMedCrossRefGoogle Scholar
  16. 16.
    Zhu, J., A.A. Quyyumi, J.E. Norman, G. Csako, M.A. Waclawiw, G.M. Shearer, et al. 2000. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. The American Journal of Cardiology 85: 140–146.PubMedCrossRefGoogle Scholar
  17. 17.
    Adiloglu, A.K., R. Can, C. Nazli, A. Ocal, O. Ergene, G. Tinaz, et al. 2005. Ectasia and severe atherosclerosis: relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflammatory markers. Texas Heart Institute Journal 32: 21–27.PubMedGoogle Scholar
  18. 18.
    Koziołek, M., B. Krzyżanowska-Świniarska, I. Mączyńska, T. Miazgowski, and S. Giedrys-Kalemba. 2008. The association between past The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women. European Journal of Clinical Microbiology and Infectious Diseases 27: 415–421.CrossRefGoogle Scholar
  19. 19.
    Fernandez-Real, J.M., M.J. Ferri, J. Vendrell, and W. Ricart. 2007. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 15: 245–252.CrossRefGoogle Scholar
  20. 20.
    Epstein, S.E., Y.F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20–e28.PubMedCrossRefGoogle Scholar
  21. 21.
    Nabipour, I., K. Vahdat, S.M. Jafari, S. Beigi, M. Assadi, F. Azizi, et al. 2008. Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: the Persian Gulf Healthy Heart Study. Endocrine Journal 55: 717–722.PubMedCrossRefGoogle Scholar
  22. 22.
    Lukaski, H.C., P.E. Johnson, W.W. Bolonchuk, and G.I. Lykken. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. American Journal of Clinical Nutrition 41: 810–817.PubMedGoogle Scholar
  23. 23.
    Lintsi, M., H. Kaarma, and I. Kull. 2004. Comparison of hand-to-hand bioimpedance and anthropometry equations versus dual-energy X-ray absorptiometry for the assessment of body fat percentage in 17–18-year-old conscripts. Clinical Physiology and Functional Imaging 24: 85–90.PubMedCrossRefGoogle Scholar
  24. 24.
    1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197.Google Scholar
  25. 25.
    Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). The Journal of the American Medical Association 285: 2486–2497.CrossRefGoogle Scholar
  26. 26.
    Kobayashi, J., S. Murano, I. Kawamura, F. Nakamura, Y. Murase, M.A. Kawashiri, et al. 2006. The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters. Journal of Atherosclerosis and Thrombosis 13: 221–226.PubMedCrossRefGoogle Scholar
  27. 27.
    Roubenoff, R., G.E. Dallal, and P.W. Wilson. 1995. Predicting body fatness: the body mass index vs estimation by bioelectrical impedance. American Journal of Public Health 85: 726–728.PubMedCrossRefGoogle Scholar
  28. 28.
    Zhu, S., Z. Wang, W. Shen, S.B. Heymsfield, and S. Heshka. 2003. Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988–1994). American Journal of Clinical Nutrition 78: 228–235.PubMedGoogle Scholar
  29. 29.
    Greenfield, J.R., K. Samaras, A.B. Jenkins, P.J. Kelly, T.D. Spector, J.R. Gallimore, et al. 2004. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109: 3022–3028.PubMedCrossRefGoogle Scholar
  30. 30.
    Thorand, B., J. Baumert, A. Doring, C. Herder, H. Kolb, W. Rathmann, et al. 2006. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184: 216–224.PubMedCrossRefGoogle Scholar
  31. 31.
    Festa, A., R. D'Agostino Jr., K. Williams, A.J. Karter, E.J. Mayer-Davis, R.P. Tracy, et al. 2001. The relation of body fat mass and distribution to markers of chronic inflammation. International Journal of Obesity and Related Metabolic Disorders 25: 1407–1415.PubMedCrossRefGoogle Scholar
  32. 32.
    Lin, C.C., S.L. Kardia, C.I. Li, C.S. Liu, M.M. Lai, W.Y. Lin, et al. 2010. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health 10: 579.PubMedCrossRefGoogle Scholar
  33. 33.
    Trayhurn, P., and J.H. Beattie. 2001. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society 60: 329–339.PubMedCrossRefGoogle Scholar
  34. 34.
    Weisberg, S.P., D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112: 1796–1808.PubMedGoogle Scholar
  35. 35.
    McDade, T.W., J.N. Rutherford, L. Adair, and C. Kuzawa. 2008. Adiposity and pathogen exposure predict C-reactive protein in Filipino women. Journal of Nutrition 138: 2442–2447.PubMedCrossRefGoogle Scholar
  36. 36.
    Thjodleifsson, B., I. Olafsson, D. Gislason, T. Gislason, R. Jogi, and C. Janson. 2008. Infections and obesity: a multinational epidemiological study. Scandinavian Journal of Infectious Diseases 40: 381–386.PubMedCrossRefGoogle Scholar
  37. 37.
    Pannacciulli, N., F.P. Cantatore, A. Minenna, et al. 2001. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International Journal of Obesity and Related Metabolic Disorders 25: 1416–1420.PubMedCrossRefGoogle Scholar
  38. 38.
    Park, H.S., J.Y. Park, and R. Yu. 2005. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Research and Clinical Practice 69: 29–35.PubMedCrossRefGoogle Scholar
  39. 39.
    Nabipour, I., M. Amiri, S.R. Imami, S.M. Jahfari, A. Nosrati, D. Iranpour, et al. 2008. Unhealthy lifestyles and ischaemic electrocardiographic abnormalities: the Persian Gulf Healthy Heart Study. Eastern Mediterranean Health Journal 14: 858–868.PubMedGoogle Scholar
  40. 40.
    Nabipour, I., M. Amiri, S.R. Imami, S.M. Jahfari, E. Shafeiae, A. Nosrati, et al. 2007. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. International Journal of Cardiology 118: 48–53.PubMedCrossRefGoogle Scholar
  41. 41.
    Pateyjohns, I.R., G.D. Brinkworth, J.D. Buckley, M. Noakes, and P.M. Clifton. 2006. Comparison of three bioelectrical impedance methods with DXA in overweight and obese men. Obesity (Silver Spring) 14: 2064–2070.CrossRefGoogle Scholar
  42. 42.
    Nabipour, I., K. Vahdat, S.M. Jafari, R. Pazoki, and Z. Sanjdideh. 2006. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovascular Diabetology 5: 25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Katayoun Vahdat
    • 1
  • Fatemeh Azizi
    • 1
  • Keivan Zandi
    • 1
  • Majid Assadi
    • 2
  • Iraj Nabipour
    • 3
  1. 1.Department of Infectious Diseases, The Persian Gulf Tropical Medicine Research CenterBushehr University of Medical SciencesBushehrIran
  2. 2.The Persian Gulf Nuclear Medicine Research CenterBushehr University of Medical SciencesBushehrIran
  3. 3.Department of Biochemistry, The Persian Gulf Marine Biotechnology Research CenterBushehr University of Medical SciencesBushehrIran

Personalised recommendations